Align Technology | ALGN - Current Assets


Align Technology reported $2.66B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
3M USD 16.71B 2.6B Sep/2026
Align Technology USD 2.66B 7.62M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Bruker USD 2.22B 121.4M Jun/2026
Cardinal Health USD 38.75B 689M Jun/2026
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
CVS Health USD 75.35B 529M Jun/2026
Danaher USD 14.79B 1.41B Sep/2026
Dentsply International USD 1.93B 83M Jun/2026
Dexcom USD 4.09B 245.1M Jun/2026
Henry Schein USD 4.6B 104M Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
McKesson USD 62.84B 5.63B Jun/2026
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Revvity USD 2.3B 169.4M Jun/2026
Solventum Corp USD 3.74B 158M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Veeva Systems USD 7.95B 117.03M Jun/2026
Waters USD 3.9B 186M Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026
Zoetis USD 6.36B 118M Jun/2026